Since 1994, Marshalls has been a committed supporter of Breakthrough T1D.
As Breakthrough T1D’s largest corporate partner, Marshalls raises more than $3 million each year through in-store fundraisers at checkout, donations from the TJX Foundation, and store support of local Breakthrough T1D chapters across the country. These combined efforts have resulted in more than $47 million in donations to-date for Breakthrough T1D, helping to advance our mission of accelerating life-changing breakthroughs to cure, prevent, and treat type 1 diabetes (T1D) and its complications.
Marshalls’ 2025 in-store fundraising campaign for Breakthrough T1D runs from Sunday, August 31, through Saturday, September 27. Find your local Marshalls here.
Creating a better future
Digital creator Kris Leeper’s type 1 diabetes journey began with his diagnosis in 2013. It was, in his own words, “terrifying.”
“My wife and I were bombarded with conflicting information,” Kris said. “We were navigating unchartered territory as a family, just two years into our marriage. I felt lost and uncertain about the future.”
T1D technology changed the game for Kris. “The introduction of a continuous glucose monitor (CGM) and pump revolutionized my outlook on living with T1D. I immediately felt better,” he said. “Access to and understanding of diabetes technology has profoundly improved my daily life.”
Kris appreciates Marshalls for bringing awareness to Breakthrough T1D’s efforts to make life-changing technologies a reality for the more than 1.5 million Americans facing T1D.
“Companies like Marshalls play a pivotal role in bringing Breakthrough T1D’s mission to the mainstream,” he said. “Marshalls’ support for advocacy, research, and fundraising demonstrates the power of a major brand in creating a better future for people living with or caring for those with T1D.”
Driving breakthroughs forward
1 in every 31 families in the U.S. are impacted by type 1 diabetes—it places a tremendous financial, emotional, and mental burden on those who live with it and their loved ones. With support from partners like Marshalls, Breakthrough T1D is making everyday life with T1D safer and easier through technology—like the CGM Kris uses, and automated insulin delivery systems.
Every donation collected through the Marshalls partnership has also helped drive critical research in cures for type 1 diabetes. From the launch of the Special Diabetes Program in 1997, to the first manufactured islets making insulin in 2014, and the FDA approval of Tzield, the first disease-modifying therapy for type 1 diabetes, Breakthrough T1D is driving innovation forward to make the condition a thing of the past.
“The future of type 1 diabetes is bright,” Kris said. “We are on the cusp of living longer, experiencing fewer complications, and enjoying a life without limits.”
Breakthrough T1D thanks Marshalls for its incredible partnership in improving and changing life with type 1 diabetes.
